-
11.MIRNA FOR TREATING DISEASES AND CONDITIONS ASSOCIATED WITH NEO-ANGIOGENESIS 有权
Title translation: MIRNA用于治疗与新血管发生有关的疾病和病症公开(公告)号:EP2663641B1
公开(公告)日:2018-03-28
申请号:EP12703604.4
申请日:2012-01-10
Applicant: InteRNA Technologies B.V.
Inventor: WEIJZEN, Sanne , SCHAAPVELD, Roeland Quirinus Jozef , BOURAJJAJ, Meriem , VAN HAASTERT, Rick Jan , GRIFFIOEN, Arjan Willem , VAN BEIJNUM, Judith Rosina , CUPPEN, Edwin Pieter Johan Gerard , BEREZIKOV, Eugene , VAN PUIJENBROEK, Andreas Alphons Franciscus Ludovicus , GOMMANS, Willemijn Maria , BABAE, Negar , VAN NOORT, Petronella Innocentia
IPC: C12N15/113 , A61K31/7105 , A61K31/713 , A61P35/00
CPC classification number: C12N15/1135 , A61P35/00 , C12N7/00 , C12N15/113 , C12N2310/141 , C12N2320/10 , C12N2320/11 , C12N2320/30 , C12N2320/31 , C12N2710/10043 , C12N2740/15043 , C12Q1/6883 , C12Q1/6886
Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA-574 molecule, an equivalent or a source thereof in a disease and condition associated with neo-angiogenesis.
-
12.MIRNA FOR TREATING DISEASES AND CONDITIONS ASSOCIATED WITH NEO-ANGIOGENESIS 有权
Title translation: US ANG ANG ANG E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E E公开(公告)号:EP2663641A1
公开(公告)日:2013-11-20
申请号:EP12703604.4
申请日:2012-01-10
Applicant: InteRNA Technologies B.V.
Inventor: WEIJZEN, Sanne , SCHAAPVELD, Roeland Quirinus Jozef , BOURAJJAJ, Meriem , VAN HAASTERT, Rick Jan , GRIFFIOEN, Arjan Willem , VAN BEIJNUM, Judith Rosina , CUPPEN, Edwin Pieter Johan Gerard , BEREZIKOV, Eugene , VAN PUIJENBROEK, Andreas Alphons Franciscus Ludovicus , GOMMANS, Willemijn Maria , BABAE, Negar , VAN NOORT, Petronella Innocentia
IPC: C12N15/113 , A61K31/7105 , A61K31/713 , A61P35/00
CPC classification number: C12N15/1135 , A61P35/00 , C12N7/00 , C12N15/113 , C12N2310/141 , C12N2320/10 , C12N2320/11 , C12N2320/30 , C12N2320/31 , C12N2710/10043 , C12N2740/15043 , C12Q1/6883 , C12Q1/6886
Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA-574 molecule, an equivalent or a source thereof in a disease and condition associated with neo-angiogenesis.
Abstract translation: 本发明涉及在与新血管生成相关的疾病和病症中的miRNA-574分子,其等同物或来源的诊断和治疗用途。
-
公开(公告)号:EP4110917A1
公开(公告)日:2023-01-04
申请号:EP21706991.3
申请日:2021-02-26
Applicant: InteRNA Technologies B.V.
Inventor: YAHYANEJAD, Sanaz , TELFORD, Bryony , VAN DEN BOSCH, Marion , ALEMDEHY, Mir Farshid , DE GUNST, Matheus Maria , VAN PINXTEREN, Laurens Adrianus Hendricus , SCHAAPVELD, Roeland Quirinus Jozef , JANICOT, Michel
IPC: C12N15/113
-
公开(公告)号:EP4013869A1
公开(公告)日:2022-06-22
申请号:EP20707290.1
申请日:2020-03-06
Applicant: InteRNA Technologies B.V.
Inventor: YAHYANEJAD, Sanaz , TELFORD, Bryony Jane , VAN DEN BOSCH, Marion Tina Jolien , ALEMDEHY, Mir Farshid , DE GUNST, Matheus Maria , VAN PINXTEREN, Laurens Adrianus Hendricus , SCHAAPVELD, Roeland Quirinus Jozef , JANICOT, Michel
IPC: C12N15/113
-
公开(公告)号:EP3704250A1
公开(公告)日:2020-09-09
申请号:EP18795661.0
申请日:2018-11-02
Applicant: InteRNA Technologies B.V.
Inventor: VAN BATTUM, Eljo Y. , VANGOOR, Vamshi R. , DERIJCK, Alwin A.H.A , SCHAAPVELD, Roeland Quirinus Jozef , PASTERKAMP, R. Jeroen
IPC: C12N15/113 , A61K31/713 , C12Q1/68
-
公开(公告)号:EP3158083A1
公开(公告)日:2017-04-26
申请号:EP15738759.8
申请日:2015-06-19
Applicant: Stichting VU-VUmc , InteRNA Technologies B.V.
Inventor: MEIJER, Gerrit Albert , DIOSDADO, Begoña , TIMMER, Lisette M. , CUPPEN, Edwin Pieter Johan Gerard , BEREZIKOV, Eugene , CERISOLI, Francesco , SCHAAPVELD, Roeland Quirinus Jozef
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , C12Q2600/158 , C12Q2600/16 , C12Q2600/178
Abstract: Methods of diagnosing colorectal cancer and precursors thereof using miRNA biomarkers are disclosed, together with kits and devices for detecting the biomarkers, and uses of the biomarkers. The biomarkers described are reliably detected in stool and demonstrate significantly different expression levels in colorectal cancer patients when compared to colorectal cancer negative patients.
Abstract translation: 公开了使用miRNA生物标志物诊断结肠直肠癌及其前体的方法,以及用于检测生物标志物的试剂盒和设备以及生物标志物的用途。 所描述的生物标志物在大便中可靠地检测到,并且与结肠直肠癌阴性患者相比在结肠直肠癌患者中表现出显着不同的表达水平。
-
17.COMBINATION FOR USE IN TREATING DISEASES OR CONDITIONS ASSOCIATED WITH MELANOMA, OR TREATING DISEASES OR CONDITIONS ASSOCIATED WITH ACTIVATED B-RAF PATHWAY 审中-公开
Title translation: 融合对患有黑色素瘤或与其相关的疾病和病症的治疗有关的疾病或病症的治疗激活的B-RAF信号公开(公告)号:EP2917348A1
公开(公告)日:2015-09-16
申请号:EP13788743.6
申请日:2013-11-06
Applicant: InteRNA Technologies B.V.
Inventor: VAN HAASTERT, Rick Jan , VAN NOORT, Petronella Innocentia , PREVOST, Grégoire Pierre André , GOMMANS, Willemijn Maria , SCHAAPVELD, Roeland Quirinus Jozef , DE GUNST, Matheus Maria , SCHULTZ, Iman Johannes , BEREZIKOV, Eugene
IPC: C12N15/113 , A61P35/00 , A61K31/713
CPC classification number: A61K31/713 , A61K31/4184 , A61K31/437 , A61K31/506 , A61K31/519 , C12N15/1135 , C12N2310/113 , C12N2310/141 , C12N2320/10 , C12N2320/31 , C12N2330/10 , A61K2300/00
Abstract: The invention relates to the therapeutic use of a combination in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway.
Abstract translation: 本发明涉及与黑素瘤或疾病或与活化的BRAF途径相关的病症有关的疾病和病症的治疗用途的组合。
-
18.A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT 有权
Title translation: miRNA分子通过其源定义,它的治疗用途EMT相关癌症公开(公告)号:EP2542678A1
公开(公告)日:2013-01-09
申请号:EP11708936.7
申请日:2011-03-04
Applicant: InteRNA Technologies B.V.
Inventor: SCHAAPVELD, Roeland Quirinus Jozef , VERHAEGH, Gerardus Wilhelmus Christiaan Theodoor , SCHALKEN, Jacobus Antonius , VAN PUIJENBROEK, Andreas Alphons Franciscus Ludovicus , GOMMANS, Willemijn Maria , WEIJZEN, Sanne
IPC: C12N15/113 , A61K31/7105 , A61P35/04
CPC classification number: C12N15/1138 , A61K31/7088 , A61K31/7105 , A61K31/713 , A61K45/06 , A61N5/10 , C12N15/113 , C12N2310/141 , C12N2320/31 , C12N2330/10
Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA molecule or an equivalent thereof wherein a source of said miRNA molecule or equivalent thereof comprises at least 80 nucleotides and comprises a motif having at least 98% identity with the motif represented by SEQ ID NO:1 or a source thereof in a disease and condition associated with EMT (Epithelial to Mesenchymal Transition).
-
-
-
-
-
-
-